Figure 3.
Figure 3. Sin3BCKO HSCs are myeloid biased. Percent of B (B220+), T (CD4+ or CD8+), and myeloid (CD11b+) cells from donor-derived peripheral blood in primary (A) and secondary (B) recipient animals 20 weeks after transplantation. (C) Representative FACS plot of CD150 surface staining of LT-HSCs of indicated genotypes. (D) Quantification of percentage of CD150HIGH, CD150LOW, and CD150NEG within the LT-HSC population; n ≥ 8. Data are represented as mean ± SEM. *P < .05; **P < .01. NS, not significant.

Sin3BCKOHSCs are myeloid biased. Percent of B (B220+), T (CD4+ or CD8+), and myeloid (CD11b+) cells from donor-derived peripheral blood in primary (A) and secondary (B) recipient animals 20 weeks after transplantation. (C) Representative FACS plot of CD150 surface staining of LT-HSCs of indicated genotypes. (D) Quantification of percentage of CD150HIGH, CD150LOW, and CD150NEG within the LT-HSC population; n ≥ 8. Data are represented as mean ± SEM. *P < .05; **P < .01. NS, not significant.

Close Modal

or Create an Account

Close Modal
Close Modal